Small G Protein Signalling Modulator 2 (SGSM2) is Involved in Oestrogen Receptor-positive Breast Cancer Metastasis Through Enhancement of Migratory Cell Adhesion Via Interaction with E-cadherin
Overview
Authors
Affiliations
The function of small G protein signalling modulators (SGSM1/2/3) in cancer remains unknown. Our findings demonstrated that SGSM2 is a plasma membrane protein that strongly interacted with E-cadherin/β-catenin. SGSM2 downregulation enhanced the phosphorylation of focal adhesion kinase (FAK; Y576/577), decreased the expression of epithelial markers such as E-cadherin, β-catenin, and Paxillin, and increased the expression of Snail and Twist-1, which reduced cell adhesion and promoted cancer cell migration. Oestrogen and fibronectin treatment was found to promote the colocalization of SGSM2 at the leading edge with phospho-FAK (Y397). The BioGRID database showed that SGSM2 potentially interacts with cytoskeleton remodelling and cell-cell junction proteins. These evidences suggest that SGSM2 plays a role in modulating cell adhesion and cytoskeleton dynamics during cancer migration.
Picolo B, Silva N, Martins M, Almeida-Souza H, de Sousa L, Polveiro R Front Med (Lausanne). 2025; 11:1302637.
PMID: 39895822 PMC: 11784343. DOI: 10.3389/fmed.2024.1302637.
Sayaman R, Miyano M, Carlson E, Senapati P, Zirbes A, Shalabi S Elife. 2024; 13.
PMID: 39545637 PMC: 11723586. DOI: 10.7554/eLife.95720.
Zhu M, Wang J Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(8):1459-1466.
PMID: 39276041 PMC: 11378053. DOI: 10.12122/j.issn.1673-4254.2024.08.04.
Piryaei Z, Salehi Z, Ebrahimie E, Ebrahimi M, Kavousi K BMC Med Genomics. 2023; 16(1):219.
PMID: 37715225 PMC: 10503144. DOI: 10.1186/s12920-023-01655-z.
Su X, Chen D, Zhu L, Jia H, Cai J, Li P Cell Death Dis. 2022; 13(3):218.
PMID: 35264562 PMC: 8907342. DOI: 10.1038/s41419-022-04598-y.